Aracely Angulo-Molina

Dr. Aracely Angulo-Molina

University of Sonora Mexico
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Atmospheric Environment
Verified
Journal Article
Closed access
Diana Meza-FigueroaDiana Meza-Figueroa
Diana Meza-Figueroa
MOMargarita De la O-Villanueva
Margarita De la O-Villanueva
MPMaria Luisa De la Parra
Maria Luisa De la Parra

1 September 2009 in Chemosphere
Verified
Journal Article
Closed access
Diana Meza-FigueroaDiana Meza-Figueroa
Diana Meza-Figueroa
RMRaina Maier
Raina Maier
MOMargarita de la O-Villanueva
Margarita de la O-Villanueva
AGAgustín Gómez-Alvarez
Agustín Gómez-Alvarez
AMAlan Moreno-Zazueta
Alan Moreno-Zazueta
JPJuan Palafox-Reyes
Juan Palafox-Reyes

1 July 2005 in Earth and Planetary Science Letters
Verified
Journal Article
Closed access
OTOscar Talavera-Mendoza
Oscar Talavera-Mendoza
JRJoaquín Ruiz
Joaquín Ruiz
GGGeorge E. Gehrels
George E. Gehrels
Diana Meza-FigueroaDiana Meza-Figueroa
Diana Meza-Figueroa
RVRicardo Vega-Granillo
Ricardo Vega-Granillo
MCMaría Fernanda Campa-Uranga
María Fernanda Campa-Uranga

16 October 2018 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
GAGabriela Aguilera
Gabriela Aguilera
CBCatherine C. Berry
Catherine C. Berry
RWRachel M. West
Rachel M. West
EGEnrique Gonzalez-Monterrubio
Enrique Gonzalez-Monterrubio
Aracely Angulo-MolinaAracely Angulo-Molina
Aracely Angulo-Molina
Miguel Mendez-RojasMiguel Mendez-Rojas
Miguel Mendez-Rojas
Sustained and safe delivery of therapeutic agents across the blood–brain barrier (BBB) is one of the major challenges for the treatment of neurological disorders as this barrier limits the ability of most drug molecules to reach the brain. Targeted delivery of the drugs used to treat these disorders could potentially offer a considerable reduction of the common side effects of their treatment. The preparation and characterization of carboxymethyl cellulose (CMC) coated magnetic nanoparticles (Fe3O4@CMC) is reported as an alternative that meets the need for novel therapies capable of crossing the BBB. In vitro assays were used to evaluate the ability of these polysaccharide coated biocompatible, water-soluble, magnetic nanoparticles to deliver drug therapy across a model of the BBB. As a drug model, dopamine hydrochloride loading and release profiles in physiological solution were determined using UV-Vis spectroscopy. Cell viability tests in Human Lung Microvascular Endothelial (HLMVE) cell cultures showed no significant cell death, morphological changes or alterations in mitochondrial function after 24 and 48 h of exposure to the nanoparticles. Evidence of nanoparticle interactions and nanoparticle uptake by the cell membrane was obtained by electron microscopy (SEM and TEM) analyses. Permeability through a BBB model (the transwell assay) was evaluated to assess the ability of Fe3O4@CMC nanoparticles to be transported across a densely packed HLMVE cell barrier. The results suggest that these nanoparticles can be useful drug transport and release systems for the design of novel pharmaceutical agents for brain therapy.

23 December 2021 in Environmental Science & Technology
Verified
Journal Article
Open access
CICynthia Faye Isley
Cynthia Faye Isley
KFKara L. Fry
Kara L. Fry
XLXiaochi Liu
Xiaochi Liu
Gabriel Michael FilippelliGabriel Michael Filippelli
Gabriel Michael Filippelli
Jane A. EntwistleJane A. Entwistle
Jane A. Entwistle
MTMark Patrick Taylor
Mark Patrick Taylor
People spend increasing amounts of time at home, yet the indoor home environment remains understudied in terms of potential exposure to toxic trace metals. We evaluated trace metal (and metalloid) concentrations (As, Cu, Cr, Mn, Ni, Pb, and Zn) and health risks in indoor dust from homes from 35 countries, along with a suite of potentially contributory residential characteristics. The objective was to determine trace metal source inputs and home environment conditions associated with increasing exposure risk across a range of international communities. For all countries, enrichments compared to global crustal values were Zn > Pb > Cu > As > Cr > Ni; with the greatest health risk from Cr, followed by As > Pb > Mn > Cu > Ni > Zn. Three main indoor dust sources were identified, with a Pb–Zn–As factor related to legacy Pb sources, a Zn–Cu factor reflecting building materials, and a Mn factor indicative of natural soil sources. Increasing home age was associated with greater Pb and As concentrations (5.0 and 0.48 mg/kg per year of home age, respectively), as were peeling paint and garden access. Therefore, these factors form important considerations for the development of evidence-based management strategies to reduce potential risks posed by indoor house dust. Recent findings indicate neurocognitive effects from low concentrations of metal exposures; hence, an understanding of the home exposome is vital.

25 January 2023 in Environmental Science: Processes & Impacts
Verified
Journal Article
Closed access
PDF file
Jessica Flood-GaribayJessica Flood-Garibay
Jessica Flood-Garibay
Aracely Angulo-MolinaAracely Angulo-Molina
Aracely Angulo-Molina
Miguel Mendez-RojasMiguel Mendez-Rojas
Miguel Mendez-Rojas
According to the World Health Organization, both indoor and urban air pollution are responsible for the deaths of around 3.5 million people annually. During the last few decades, the interest in understanding the composition and health consequences of the complex mixture of polluted air has steadily increased. Today, after decades of detailed research, it is well-recognized that polluted air is a complex mixture containing not only gases (CO, NOx, and SO2) and volatile organic compounds but also suspended particles such as particulate matter (PM). PM comprises particles with sizes in the range of 30 to 2.5 μm (PM30, PM10, and PM2.5) and ultrafine particles (UFPs) (less than 0.1 μm, including nanoparticles). All these constituents have different chemical compositions, origins and health consequences. It has been observed that the concentration of PM and UFPs is high in urban areas with moderate traffic and increases in heavy traffic areas. There is evidence that inhaling PM derived from fossil fuel combustion is associated with a wide variety of harmful effects on human health, which are not solely associated with the respiratory system. There is accumulating evidence that the brains of urban inhabitants contain high concentrations of nanoparticles derived from combustion and there is both epidemiological and experimental evidence that this is correlated with the appearance of neurodegenerative human diseases. Neurological disorders, such as Alzheimer's and Parkinson's disease, multiple sclerosis, and cerebrovascular accidents, are among the main debilitating disorders of our time and their epidemiology can be classified as a public health emergency. Therefore, it is crucial to understand the pathophysiology and molecular mechanisms related to PM exposure, specifically to UFPs, present as pollutants in air, as well as their correlation with the development of neurodegenerative diseases. Furthermore, PM can enhance the transmission of airborne diseases and trigger inflammatory and immune responses, increasing the risk of health complications and mortality. Therefore, understanding the different levels of this issue is important to create and promote preventive actions by both the government and civilians to construct a strategic plan to treat and cope with the current and future epidemic of these types of disorders on a global scale.